Orchid Pharma share price BSE, Orchid Pharma Q3 result: Orchid Pharma shares on Friday, February 9, skyrocketed in opening deals after the pharma company registered a strong set of results for the third quarter that ended on December 31, 2023, on Thursday post-market hours.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The stock gained as much as 19.9 per cent to clock a fresh 52-week high of Rs 1,054.4 apiece on the BSE. The stock closed Rs 137.15 or 15.61 per cent stronger at Rs 1,015.85 on BSE. 

Orchid Pharma Q3 results

The company recorded a 3.6-fold jump in its net profit at Rs 29.43 crore for Q3 against a profit of Rs 7.58 crore logged a year ago. The company's income from operations/ net revenue grew by 38.1 per cent and stood at Rs 198.75 crore for the quarter under review, compared to Rs 602.26 crore registered in the corresponding quarter of the previous fiscal.

Orchid Pharma's margin, a key measure of profitability for a business, stood at 16.2 per cent in comparison to 8.7 per cent.

Orchid Pharma shares: Past performance

Orchid Pharma's stock has given a give over 150 per cent return in the last 12 months (from February 10, 2023). In comparison, the headline index Nifty 50 has rallied nearly 22 per cent.

Catch the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.